Tag: Health Claims

Displaying 1 - 20 of 241 results.

Pages

Filtering by content type: Press Release

The Federal Trade Commission sent cease-and-desist letters to 10 companies suspected of advertising unproven treatments or cures for diabetes, ordering the companies to stop making unsubstantiated claims within 15 days or face potential legal action by the FTC.
The Federal Trade Commission and the Georgia Attorney General’s Office today sued the co-founders of the Stem Cell Institute of America for marketing stem cell therapy to seniors nationwide using bogus claims that it is effective in treating arthritis, joint pain, and a range of other orthopedic...
The Federal Trade Commission is sending refund checks totaling more than $350,000 to consumers who bought Willow Curve, a device that applies low-level light and, according to the agency, was deceptively advertised as an effective way to relieve pain.
The Federal Trade Commission testified before the House Energy and Commerce Subcommittee on Consumer Protection and Commerce on legislation to modify the FTC’s authority and address other pressing issues facing the agency.
The Federal Trade Commission charged an online marketer with falsely promising consumers that he could quickly deliver facemasks and other personal protective equipment during the COVID-19 pandemic, then failing to deliver on customers’ orders or offer cancellations or refunds.
The medical director of California-based Golden Sunrise Nutraceutical, Inc., agreed to settle Federal Trade Commission charges that he took part in deceptively advertising a $23,000 treatment plan as a scientifically proven way to treat COVID-19. Dr. Stephen Meis will be barred from making similar...
Following a public comment period, the Federal Trade Commission has approved final administrative consent orders against three companies, BASF SE, its subsidiary, BASF Corp.
The Federal Trade Commission has joined the U.S. Food and Drug Administration (FDA) in sending warning letters to five companies that may be making false or unsubstantiated claims that their products can cure, treat, mitigate, or prevent infertility and other reproductive disorders in violation of...
The Federal Trade Commission today announced its latest law enforcement action to halt deceptive health and efficacy claims in the growing market for cannabidiol (CBD) products.
The Federal Trade Commission announced that 30 more marketers nationwide have stopped making unsubstantiated claims that their products and therapies can prevent or treat COVID-19, the disease caused by the novel coronavirus. The marketers removed these claims after receiving FTC warning letters...
In testimony today before the Senate Commerce Committee’s Subcommittee on Consumer Protection, Product Safety, and Data Security, the Federal Trade Commission provided an update on its work to protect consumers from scams and frauds related to the COVID-19 pandemic.
In testimony before the Senate Commerce Committee, the Federal Trade Commission updated lawmakers on its efforts to combat scams and address other consumer issues related to the COVID-19 pandemic, while urging lawmakers to ensure the agency has the authority it needs to prohibit illegal conduct and...
The Federal Trade Commission staff issued a report highlighting the agency’s ongoing efforts to protect consumers during the COVID-19 pandemic. The report addresses challenges consumers face during the pandemic and details the Commission’s strategy to combat COVID-related fraud and other consumer...
The Federal Trade Commission charged St. Louis-based chiropractor Eric Anthony Nepute and his company Quickwork LLC with violating the COVID-19 Consumer Protection Act and the Federal Trade Commission Act, by deceptively marketing products containing vitamin D and zinc as scientifically proven to...
Two companies, BASF SE and DIEM Labs, will pay a total of more than $416,000 to settle Federal Trade Commission charges that they deceptively marketed two dietary fish oil supplements as clinically proven to reduce liver fat in adults and children with non-alcoholic fatty liver disease (NAFLD). The...
Following a public comment period, the Federal Trade Commission has approved final administrative consent orders against six companies selling cannabidiol (CBD) products nationwide.
A Baltimore-based company, Agora Financial, LLC, and several of its affiliates have agreed to pay more than $2 million to settle Federal Trade Commission charges that they tricked seniors into buying pamphlets, newsletters, and other publications that falsely promised a cure for type 2 diabetes or...
One of the defendants behind an alleged sham health insurance scheme has been permanently banned from the health care business as part of a settlement with the Federal Trade Commission.
Note: The FTC hosted a media call-in on this announcement with Andrew Smith, Director, Bureau of Consumer Protection on Thursday, December 17, 2020.  
The Federal Trade Commission today issued a new consumer education blog post with the National Association of Attorneys General, offering tips on how to recognize and avoid vaccine-related scams. According to the post, with COVID-19 vaccines in the pipeline, scammers will not be far behind, and...

Pages